Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Statement of Comprehensive Income [Abstract]
Net loss	$ (56,584)	$ (67,883)
Other comprehensive loss
Net unrealized gain on marketable securities	33	121
Comprehensive loss	(56,551)	(67,762)
Comprehensive loss attributable to non-controlling interest	(26,550)	(33,852)
Comprehensive loss attributable to Rani Therapeutics Holdings, Inc.	$ (30,001)	$ (33,910)